Do patients with low volume prostate cancer have prostate specific antigen recurrence following radical prostatectomy? | Journal of Clinical Pathology
SciELO - Brasil - PSA kinetics before 40 years of age PSA kinetics before 40 years of age
Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice
Changes in PSA after one year of TRT | Download Table
PSA Testing | ZERO Prostate Cancer
PSA-IP - Viking Electronics, Inc.
Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy | PLOS ONE
Test May Show Whether to Treat Prostate Cancer with Hormones - NCI
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml | PLOS ONE
Frontiers | Evaluation and multi-institutional validation of a novel urine biomarker lncRNA546 to improve the diagnostic specificity of prostate cancer in PSA gray-zone
Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies | Prostate Cancer and Prostatic Diseases
Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future | Nature Reviews Urology
PDF) The possibilities of age reference values of PSA density in prostatic cancer screening
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
Clinical Case Discussions - Rising PSA 18 Months Post RP and Timing of Radiotherapy | Rising PSA 18 months post-RP & timing of radiotherapy. Ashley Ross, MD, PhD Northwestern University Feinberg School
Comparison of ROC curves for free PSA, total PSA, %-free PSA, and... | Download Scientific Diagram
ESMO 2022: Association between prostate-specific antigen decline and clinical outcomes in patients with metastatic castration-resistant prostate cancer in the VISION trial
xmlinkhub
